Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

NCT00852540 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Infections, Bacterial

Interventions

DRUG: Retpamulin Ointment, 1%
DRUG: Linezolid

Sponsor

Stiefel, a GSK Company

Collaborators

[object Object]